Shree Ganesh Remedies appoints Hiral Shah as independent director
Shree Ganesh Remedies Ltd has appointed Ms. Hiral Ankitkumar Shah as a Non-Executive Independent Director for a five-year term effective July 17, 2026, pending shareholder approval. Ms. Shah, a qualified Company Secretary with over 14 years of experience, currently serves as the Company Secretary and Compliance Officer at UMA Converter Limited.
*this image is generated using AI for illustrative purposes only.
Shree Ganesh Remedies Ltd has appointed Ms. Hiral Ankitkumar Shah as a Non-Executive Independent Director on its Board, effective July 17, 2026. The appointment is for a term of five years, subject to the approval of the shareholders. This strategic addition to the Board aims to strengthen the company's corporate governance framework with Ms. Shah's extensive expertise in legal and secretarial compliance.
The Board of Directors approved the appointment based on the recommendation of the Nomination and Remuneration Committee. The decision was taken in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the applicable provisions of the Companies Act, 2013. Ms. Shah has confirmed that she is not debarred from holding the office of Director by any order of SEBI or other regulatory authorities.
Ms. Hiral Shah is a qualified Company Secretary and holds a Master's degree in Commerce (M.Com.) and a Bachelor of Laws (LL.B.). She possesses over 14 years of experience in corporate governance, legal, secretarial, and regulatory compliance for both private and listed companies. Her expertise includes the administration of the Companies Act, 2013, SEBI Listing Regulations, securities laws, and advising management on regulatory affairs.
Currently, Ms. Shah serves as the Company Secretary and Compliance Officer of UMA Converter Limited. In this role, she oversees secretarial, legal, regulatory, and corporate governance functions, ensuring compliance with applicable laws. The company disclosed that there are no specific relationships between directors requiring disclosure under the current regulations.
The details of the appointment were submitted to BSE Limited under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. A copy of the intimation has been made available on the company's website.
Appointment Details
| Particulars | Details |
|---|---|
| Name of Director | Ms. Hiral Ankitkumar Shah |
| DIN | 07164025 |
| Designation | Non-Executive Independent Director |
| Date of Appointment | July 17, 2026 |
| Term | Five years |
| Shareholder Approval | Required |
Historical Stock Returns for Shree Ganesh Remedies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +7.19% | -0.32% | -2.66% | +58.33% | +11.24% | +96.53% |
How will Ms. Shah's specific expertise in regulatory compliance influence Shree Ganesh Remedies' future governance policies?
What strategic initiatives is the board likely to prioritize with the addition of her legal and secretarial background?
Could this appointment signal a shift in the company's approach to navigating complex securities laws and SEBI regulations?
15
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
